The pattern is mainly that of a grade B nitrogen mustard type response, with the neutrophils being depressed more than the lymphocytes (L/N about 0 75) but it shows a modified hump in the neutrophil response curve similar to that shown inthe response to X-irradiation and a delayed platelet fall characteristic of the response to Myleran and to X-irradiation. Mannitol Myleran thus behaves like a mixture of a Myleranlike component and a grade B nitrogen-mustardlike component, and shows an interesting comparison with X-irradiation which behaves like a mixture of Myleran and a grade A nitrogen mustard (such as chlorambucil). The response pattern is very similar to that of X-irradiation except that the magnitude of the depressive effects on lymphocytes and neutrophils are reversed, Xrays causing the greater effect on lymphocytes, and mannitol Myleran on neutrophils. The dual nature of the response to mannitol Myleran throws an interesting light on its mode of action; experiments are in progress which suggest that it is partially converted in vivo to an epoxide derivative, which is responsible for the nitrogen-mustard-like component of the response pattern which is thus superimposed on the expected Myleran type response of a compound so closely related to Myleran itself. Acad. Scd. 68, 826 (1958b) VII Int. Congr. Hemat. 3, 647 (1960 ) Biochem. Pharmacol. 5, 192 (1963 Many malignant conditions may be associated with changes in y globulin, for example multiple myeloma invariably causes y globulin abnormalities, and Dr Innes will discuss this disease (p 648). However, abnormalities in y globulin may arise in other malignant diseases of lymphoreticular tissue and may themselves cause clinical syndromes which may alter the course and prognosis of the disease and demand treatment, quite apart from treatment for the underlying disease; the syndromes to be discussed are macroglobulinoemia, cryoglobulinemia, autoimmune haemolytic anemia, and hypogammaglobulinmeia.
Macroglobulinemia
Macroglobulineemia was first described by Wal-denstr6m in 1944, and has recently been reviewed by Martin (1960) , who considers that at least 10 % of the serum proteins should have a sedimentation value greater than S2ow16 for the diagnosis to be made (Martin & Closel957) . Macroglobulinemia may arise in a number of diseases, such as chronic lymphatic leukemia, lymphosarcoma and even Hodgkin's disease, which themselves require treatment. However, the presence ofthe macroglobulin in the plasma may cause symptoms: for example, a hemorrhagic diathesis with epistaxis, hmemoptysis, and bleeding gums; a retinopathy and heart failure probably due to a mixture of increased viscosity of the blood and anemia. Treatment may therefore be directed either against the proliferating cells forming the macroglobulin, that is cells of the lymphocyte-plasma cell series, or a direct attack may be made against the protein itself, or the macroglobulin may be removed from the serum by plasmapheresis. (a) Treatment directed against the cells forming macroglobulin: The two groups of drugs most commonly used are the nitrogen mustards and corticosteroids; they have often been given together so that it is sometimes difficult to assess which of the two has been responsible for any improvement. However, in some cases they have been used alone, and each may be of value.
In a case described by Ferriman & Anderson (1956) the abnormal macroglobulin disappeared from the serum and the retinopathy returned to normal following treatment with mustine hydrochloride and cortisone, and there has been no recurrence since then, a period of seven years (Ferriman 1963, personal comniunication) . Chlorambucil has also proved effective, but it must be given for a long time (many months), and usually leads to a symptomatic improvement and a reduction, but not disappearance, of the abnormal protein (Bayrd 1961 , Kok 1962 . Similar results may occur with cyclophosphamide (Martin 1963, personal communication) .
Symptomatic improvement and a reduction in the amount of circulating macroglobulin has also been reported following treatment with prednisone (Glenchur et al. 1958 , Pitney et al. 1958 ), which has also been used with good results in combination with other drugs, including androgens and cestrogens to arrest bleeding (Martin 1963, personal communication) . We used prednisone with 6-mercaptopurine in a case of lymphatic leukvmia in which the abnormal macroglobulin virtually disappeared from the serum. (b) Treatment designed to cause dissociation of the macroglobulin: Macroglobulins are aggregates of smaller globulin fractions joined by sulphydryl linkages, and are therefore capable of being split into these smaller components by sulphydrylreducing agents (Deutsch & Morton 1957) . This can readily be accomplished in the laboratory by a variety of such compounds, including penicillamine, and this has been used in man. Some workers have reported a reduction in the concentration of circulating macroglobulin ), but others have been unsuccessful (Dacie 1962 , Kok 1963 . Thus it seems certain that although macroglobulins can always be dissociated in vitro by sulphydryl-reducing compounds, in vivo the results are variable and usually disappointing, probably because a sufficient concentration of penicillamine in the plasma cannot be attained.
(c) Removal of macroglobulin by plasmapheresis: Removal of macroglobulin from the body can be achieved by plasmapheresis, although the protein will accumulate again, and therefore to obtain any long-term benefit it has to be repeated at weekly intervals. Plasmapheresis is certainly useful in an emergency when there is severe cardiac failure or retinopathy, both of which may resolve completely after the concentration of macroglobulin in the serum k reduced , Conway & Walker 1962 . Conway & Walker (1962) adopted the simple technique of taking blood from the patient into citrate, and then inverting the bottle.
The very high ESR produced virtually complete separation of the cells from the plasma within one hour, enabling the red cell layer to be transfused back into the patient without the plasma.
In addition, other methods of treatment, including radioactive phosphorus (Curtain 1959 , Mackay 1959 ) and splenectomy (Long et al. 1955 , Mackay 1959 , have produced temporary im-provement. described a case where surgical removal of a lymphosarcoma of the brain was followed by disappearance of a macroglobulin from the plasma, but such an occurrence must be very rare.
Therefore, in summary, long-term treatment of macroglobulinwmia may be attempted by using drugs acting against the cells forming macroglobulinthat is one of the nitrogen mustards or corticosteroids; or by drugs such as penicillamine which cause dissociation of macroglobulins, but although this is theoretically attractive, in practice results are disappointing. In emergency treatment of heart failure, retinopathy or uncontrolled hEemorrhage plasmapheresis is most effective.
Cryoglobulinwmia
Whenever an abnormal y globulin is present in the plasma in high concentration it may have the physical property of precipitating in the cold, and the patient is said to have cryoglobulinwmia. The abnormal y globulin may be a macroglobulin (19S), or a smaller 7S globulin and therefore the phenomenon of cryoglobulinmmia may occur with macroglobulinmmia, multiple myeloma or in other reticuloses, such as lymphosarcoma and chronic lymphatic leukEemia, associated with hypergammaglobulinemia. The presence of cryoglobulin may lead to cold sensitivity and Raynaud's phenomenon as well as leg ulceration and a haemorrhagic diathesis.
Apart from protection against the cold, the treatment of cryoglobulinemia depends on the nature of the underlying disease and the type of y globulin present. Treatment for macroglobulinamia has already been discussed, and Dr Innes will discuss multiple myeloma; in lymphosarcoma and chronic lymphatic leukaemia, the nitrogen mustards, steroid hormones, and 6-mercaptopurine are the three most useful groups of drugs.
Autoimmuine Ha?molytic Anwmia
In some malignant diseases, particularly primary malignant diseases of lymphoreticular tissue such as lymphosarcoma and chronic lymphatic leukmmia, an abnormal y globulin may be formed which acts as an antibody and becomes attached to the surface of the red blood cells, giving rise to a positive direct Coombs test and a hwemolytic anemia. As with cryoglobulinaemia, the abnormal y globulin may be a macroglobulin (19S), in which case it acts as a 'cold' antibody, or the smaller 7S globulin, in which case it is a 'warm' antibody. The distinction is important, since the clinical and pathological features, as well as the treatment, are different with the two types.
With the warm-antibody disease, the 7S globulin becomes adsorbed to the surface of the red cells and often leads to their destruction in the spleen more than in other parts of the reticuloendothelial system (Jandl 1955 , Mollison & Hughes Jones 1958 ; in this variety both steroid therapy and splenectomy may be effective (Dacie 1962) . Indeed, many would regard haemolytic anemia of this type as an absolute indication for treatment with corticosteroids in diseases such as chronic lymphatic leukaemia and lymphosarcoma. Recently Dameshek and his colleagues (Schwartz & Dameshek 1962) have successfully treated patients with this type of haemolytic aneemia with 6-mercaptopurine, thioguanine, and Imuran. By contrast, with cold antibodies the red cells also become coated with complement and tend to be destroyed throughout the reticulo-endothelial system; here corticosteroids, splenectomy and 6-mercaptopurine prove disappointing. Since cold antibodies are macroglobulins, sulphydrylreducing compounds have been tried and there has been a report of one patient in whom treatment with penicillamine has been successful , but in other patients it has failed to influence the disease (Dacie 1962) .
In summary, the warm-antibody disease is due to a 7S y globulin, the red cells are destroyed chiefly in the spleen, response to treatment with corticosteroids, splenectomy and 6-mercaptopurine is often good, although there are some cases that fail to respond and the disease may be rapidly fatal. The cold-antibody disease is due to a 19S (macroglobulin), the red cells are destroyed throughout the reticulo-endothelial system, and response to treatment with corticosteroids, splenectomy and 6-mercaptopurine is usually poor.
Hypogammaglobulinamia
Although acquired hypogammaglobulinemia may be caused by a variety of diseases, chronic lymphatic leukaemia is probably the commonest single cause in adults, being present in up to 67 % of patients with this disease (Fa-irley & Scott 1961) . It also occurs in other malignant diseases of the lymphocyte-plasma cell series such as multiple myeloma and lymphosarcoma, as well as benign diseases such as amyloidosis and sarcoidosis.
The importance of hypogammaglobulinamia, with the associated failure to form circulating antibodies, is that it leads to recurrent and troublesome bacterial infections. This may be treated by weekly injections of y globulin, and we have recently had a patient in whom the serum y globulin was in the range for treatment laid down by the M.R.C. Working Party on Hypogammaglobulinaemia (that is, less than 200 mg/100 ml, measuring the y globulin by immunological techniques, (Squire 1960) . This patient was treated with y globulin kindly supplied by Dr W d'A Maycock of the Lister Institute from April 1959 until her death from chronic lymphatic leukemia in December 1962. In the year before treatment she had eighteen infective episodes and during the three and a half years that she was receiving y globulin, she averaged four infections per year. The injections were unquestionably painful, but the patient was convinced that the treatment was worth while (Fairley & Scott 1961) .
It is no coincidence that all the malignant diseases in which these various y globulin abnormalities most commonly occur should be primary malignant diseases of lymphocytes and plasma cells. In these diseases there is frequently a failure to produce normal y globulin, with inability to form circulating antibodies against foreign antigens and, at the same time, there may be the production of an abnormal y globulin. Thus, in multiple myeloma there is frequently hypogammaglobulinemia when the y globulin is measured by immunological techniques, despite an increased concentration on electrophoresis. Similarly, in chronic lymphatic leukemia severe hypogammaglobulinoemia may be accompanied by an autoimmune hiemolytic anemia (Pisciotta et al. 1960 ).
Since these y globulin abnormalities are usually quite easy to detect in the laboratory by Coombs tests, electrophoresis, cooling the serum and the Sia water test, it is important, particularly in malignant diseases of lymphoreticular tissue, to look for them at regular intervals, so that the various syndromes associated with these changes may be diagnosed early in the disease and the appropriate treatment given.
